🇮🇳印度·初創企業·2026年5月27日·來源： The Economic Times
Tata-backed MedTherapy claims CAR-T breakthrough with one-day production
內容只提供英文版本
Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can reduce production time from several weeks to just one day and cut costs by nearly 70%, potentially making advanced cancer treatment more affor...
分享這篇文章
原文報道： The Economic Times我們不轉載全文， 閱讀原文 →
